Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
JMS Co., Ltd. is currently navigating 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These 2 actions are assigned to 2 distinct examiners but are both located within 1 distinct art unit. This suggests that while different individuals are reviewing the applications, the company's current prosecution is administratively centralized within a single department. This departmental concentration can be advantageous for maintaining consistency in how technical terms or prior art are treated across the 2 pending office actions.
The busiest examiner for this portfolio is NGO, MEAGAN N, who is responsible for 1 pending office action. Given that there are 2 pending actions and 2 distinct examiners, each examiner is handling exactly 1 action. For practitioners, this means that while they must interact with 2 different examiners, they only need to account for the specific policies and standards of 1 art unit. This provides a consistent departmental framework for both active matters. The strategy should focus on the specific procedural norms of this 1 art unit while tailoring technical arguments to the individual preferences of the 2 examiners. This centralized departmental oversight allows for a more unified prosecution approach compared to portfolios spread across multiple art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGO, MEAGAN N | 1 | 58.3% | +33.1% |
| WIEST, PHILIP R | 1 | 81.3% | +16.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17802733 | BLOOD PROCESSING FILTER | WIEST, PHILIP R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18552519 | BLOOD CIRCULATION CIRCUIT | NGO, MEAGAN N | — |
| 17802733 | BLOOD PROCESSING FILTER | WIEST, PHILIP R | — |
| Art Unit | Apps |
|---|---|
| 3781 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18552519 | BLOOD CIRCULATION CIRCUIT | NGO, MEAGAN N | 3781 | §103 | Final Rejection | — | Pending | Sep 26, 2023 |
| 17802733 | BLOOD PROCESSING FILTER | WIEST, PHILIP R | 3781 | §103 | Non-Final OA | — | Pending | Aug 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial